These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1914032)

  • 41. Reproductive hormones and hypothalamic-pituitary-ovarian axis in female patients with homozygous beta-thalassemia major.
    Safarinejad MR
    J Pediatr Hematol Oncol; 2010 May; 32(4):259-66. PubMed ID: 20445415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Value of basal serum gonadotropin levels in the diagnosis of precocious puberty in girls].
    Liang JT
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):942-5. PubMed ID: 23234783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
    Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monthly urinary gonadotropin and ovarian hormone excretory patterns in normal girls and female patients with idiopathic precocious puberty.
    Maesaka H; Tachibana K; Adachi M; Okada T
    Pediatr Res; 1996 Dec; 40(6):853-60. PubMed ID: 8947962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone.
    Luder AS; Holland FJ; Costigan DC; Jenner MR; Wielgosz G; Fazekas AT
    J Clin Endocrinol Metab; 1984 Jun; 58(6):966-72. PubMed ID: 6427266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. True precocious puberty in a girl with the fragile X syndrome.
    Moore PS; Chudley AE; Winter JS
    Am J Med Genet; 1990 Oct; 37(2):265-7. PubMed ID: 2123375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autonomous ovarian hyperfunction followed by gonadotrophin-dependent puberty in McCune-Albright syndrome.
    Kaufman FR; Costin G; Reid BS
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):239-42. PubMed ID: 3085997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor.
    Jenner MR; Kelch RP; Kaplan SL; Grümbach MM
    J Clin Endocrinol Metab; 1972 Mar; 34(3):521-30. PubMed ID: 5011256
    [No Abstract]   [Full Text] [Related]  

  • 51. [Transitory precocious puberty caused by autonomous ovarian cysts. Clinical, endocrinologic and sonographic course].
    Partsch CJ; Kreller-Laugwitz G; Sippell WG
    Monatsschr Kinderheilkd; 1989 Apr; 137(4):235-8. PubMed ID: 2499771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
    Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
    N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog.
    Maffeis C; Franceschi R; Moghetti P; Camilot M; Lauriola S; Tatò L
    Eur J Endocrinol; 2007 Jan; 156(1):99-103. PubMed ID: 17218731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The immature HPO axis.
    Buttram VC
    J Reprod Med; 1975 Jan; 14(1):21-5. PubMed ID: 1089157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persistence of autonomous ovarian activity after discontinuation of therapy for precocious puberty in McCune-Albright syndrome.
    Escobar ME; Gryngarten M; Domené H; Ropelato G; López MR; Bergadá C
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):147-51. PubMed ID: 9288659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment.
    Su PH; Wang SL; Lin CY; Chen JY; Changlai CP; Jian SH; Chen SJ
    Acta Paediatr Taiwan; 2005; 46(5):278-83. PubMed ID: 16640001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Further Exploration on the Essence of Yin Deficiency Caused Fire Hyperactivity Syndrome in Precocious Puberty Children Patients].
    Huang R; Zeng GZ; Huang HY; Wang YH; Yu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):879-881. PubMed ID: 30634219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged activation of hypothalamo-pituitary-ovarian axis during early infancy in female patients with salt-losing 21-hydroxylase deficiency.
    Maesaka H; Suwa S; Tachibana K; Katsumata N
    Pediatr Res; 1985 Dec; 19(12):1258-62. PubMed ID: 3936012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.